
1. antimicrob agents chemother. 2012 mar;56(3):1281-90. doi: 10.1128/aac.05571-11.
epub 2011 dec 12.

a novel carbon monoxide-releasing molecule fully protects mice severe
malaria.

pena ac(1), penacho n, mancio-silva l, neres r, seixas jd, fernandes ac, rom√£o
cc, mota mm, bernardes gj, pamplona a.

author information: 
(1)unidade de imunologia molecular, instituto de medicina molecular, universidade
de lisboa, lisbon, portugal.

severe forms malaria infection, cerebral malaria (cm) acute lung
injury (ali), mainly caused apicomplexan parasite plasmodium
falciparum. primary therapy quinine artemisinin derivatives generally 
effective controlling p. falciparum parasitemia, mortality cm and
other forms severe malaria remains unacceptably high. herein, report the
design synthesis novel carbon monoxide-releasing molecule (co-rm;
alf492) fully protects mice experimental cm (ecm) ali. alf492
enables controlled co delivery vivo without affecting oxygen transport by
hemoglobin, major limitation co inhalation therapy. protective effect 
is co dependent induces expression heme oxygenase-1, contributes
to observed protection. importantly, used combination the
antimalarial drug artesunate, alf492 effective adjunctive adjuvant
treatment ecm, conferring protection onset severe disease. 
study paves way potential use co-rms, alf492, as
adjunctive/adjuvant treatment severe forms malaria infection.

doi: 10.1128/aac.05571-11 
pmcid: pmc3294911
pmid: 22155828  [indexed medline]

